You have 9 free searches left this month | for more free features.

Condition

B-cell Non Hodgkin Lymphoma (1)

Metastatic Non-squamous Non Small Cell Lung Cancer (1)

Richter's Transformation (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Checkpoint Therapeutics, Inc. (1)

TG Therapeutics, Inc. (1)

Collaborator

Intervention

cosibelimab (2)

carboplatin (1)

cisplatin (1)

cosibelimab + ublituximab + bendamustine combination (1)

dexamethasone 4mg (1)

folic acid 350-1000 μg (1)

pemetrexed (1)

vitamin b12 1000 μg (1)

Study Documents

Intervention Type

drug (2)

dietary supplement (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

cosibelimab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

B-cell Non Hodgkin Lymphoma, Richter's Transformation Trial in United States (Cosibelimab, Cosibelimab + Ublituximab +

Terminated

B-cell Non Hodgkin Lymphoma
Richter's Transformation

Cosibelimab
Cosibelimab + Ublituximab + Bendamustine combination

Huntsville, Alabama
+8 more

Aug 19, 2022

Metastatic Non-squamous Non Small Cell Lung Cancer Trial in Worldwide (Cosibelimab, Cisplatin, Carboplatin)

Active, not recruiting

Metastatic Non-squamous Non Small Cell Lung Cancer

Cosibelimab
+6 more

Vitória, Brazil
+21 more

Aug 17, 2022